✅ CONDITIONALLY RECOMMENDED for users seeking comprehensive weight loss support combining GLP-1 medication with behavior change coaching. Best for those committed to long-term habit formation. Use monthly billing only and document all transactions. NOT recommended for those wanting simple medication-only service or anyone uncomfortable with compounded medications.
Drugs: Compounded semaglutide, compounded tirzepatide, Wegovy, Zepbound, and metformin. Regular Monthly Price: $119/month (GLP-1Rx Program). Lowest Monthly Price: $69/month (base membership, meds via insurance).
Noom Med combines GLP-1 medications with psychology-based coaching and their proprietary apps, differentiating from medication-only competitors. The platform has 4.4/5 stars on Trustpilot with 65,000+ reviews and an A+ BBB rating, though it carries baggage from a $62 million class action settlement over deceptive billing practices in 2022.
The GLP-1Rx Program at $129/month includes compounded medication, unlimited clinician access, and the GLP-1 Companion app with features like Muscle Defense programming and injection tracking. All programs include Noom's weight loss app with food tracking and coach support. Branded medication costs are separate for the telehealth program, running $500-1,500+ monthly without insurance.
In July 2025, Eli Lilly terminated their partnership with Noom over the company's refusal to stop selling compounded medications despite FDA shortage resolutions, potentially limiting branded Zepbound access. The company continues offering compounded options through FDA-regulated 503B pharmacies, though these are not FDA-approved medications.
"Users seeking a comprehensive weight loss program that combines GLP-1 medication with behavior change coaching, food tracking, and psychology-based habit formation rather than medication alone
Budget-conscious users wanting simple medication-only service, those requiring guaranteed branded medication access, users uncomfortable with compounded medications or their legal uncertainty, or anyone with concerns about billing practices given the company's $62M settlement history
Comprehensive behavior change approach combining GLP-1 medication with psychology-based coaching, 17+ years of operational history, proprietary GLP-1 Companion app with Muscle Defense program, and documented 39% better weight loss outcomes versus medication alone
Major $62 million class action settlement for deceptive auto-renewal practices (2022), Eli Lilly partnership terminated (July 2025) over compounded medication sales, and ongoing billing complaints despite improved practices
Regular Price
$129/month
Promotional Price
Starting at $129
Dosing: Weekly injection, SmartDose titration protocol up to 2.4mg
Included: Medication, unlimited clinician access, GLP-1 Companion app, Taper-Off Guarantee
Primary offering through GLP-1Rx Program. Produced in FDA-regulated 503B pharmacies but NOT FDA-approved.
Regular Price
$129/month
Promotional Price
Starting at $129
Dosing: Weekly injection
Included: Medication, unlimited clinician access, GLP-1 Companion app
Available through GLP-1Rx Program. Continued sales led to Eli Lilly partnership termination in July 2025.
Regular Price
$1,000-1,500/month without insurance
Promotional Price
Insurance copay varies
Dosing: Weekly injection
Included: Prescription support only - medication cost separate
Available through Telehealth for Branded Medications program ($69/month).
Regular Price
$500-1,000/month without insurance
Promotional Price
Insurance copay varies
Dosing: Weekly injection
Included: Prescription support only
LillyDirect partnership TERMINATED July 2025. Branded access may be limited.
Regular Price
$89/month
Promotional Price
$69 to start
Dosing: Oral daily
Included: Medication included in program price
Weight-Loss Pill program. Budget-friendly option.
| Product | Regular Price | Promo Price | State Variations |
|---|---|---|---|
| GLP-1Rx Program (Compounded Semaglutide/Tirzepatide) | $129/month | Starting at $129 | Not available in NY, NJ, RI without insurance |
| Telehealth for Branded Medications | $69/month | $69 to start | Medication costs extra ($500-1,500/month) |
| Weight-Loss Pill (Metformin) | $89/month | $69 to start | Medication included |
Noom Weight App Features
Psychology-based curriculum, food tracking, coach support
GLP-1 Companion App
Muscle Defense program, injection tracking, side effect management
Branded Medication Cost
Telehealth program provides prescription support only - medication separate
Unlike medication-only providers, Noom combines GLP-1s with psychology-based coaching, food tracking, and habit formation. Company-cited study shows 39% better weight loss than GLP-1 alone.
Impact: Users get more than just medication - they build sustainable habits.
$624M+ funding from major investors (Silver Lake, Sequoia, Kleiner Perkins). 17 years operational history. 50M+ app downloads.
Impact: Not a fly-by-night startup. Financial stability reduces risk of company closure.
Purpose-built app includes Muscle Defense program, injection tracking, side effect management resources.
Impact: Specialized tools support GLP-1 journey specifically.
Company responds to 99% of negative Trustpilot reviews within 24 hours. A+ BBB rating shows responsiveness when escalated.
Impact: Public escalation effective for resolution.
BBB rating improved from D (August 2020) to A+ after $62M settlement and business practice changes.
Impact: Demonstrates accountability and willingness to improve.
Nichols v. Noom Inc. settled for $56M cash + $6M subscription credits. Former engineer testified cancellation was 'difficult by design.'
Impact: Serious trust concern. Historical pattern of prioritizing revenue over customer experience.
Lilly ended LillyDirect partnership July 2025 because Noom refused to stop selling compounded tirzepatide despite FDA shortage ending.
Impact: Raises questions about branded medication access. Creates legal uncertainty.
While produced in FDA-regulated 503B pharmacies, compounded semaglutide and tirzepatide are NOT approved by FDA for safety and efficacy.
Impact: Users not getting FDA-approved medications. Potential supply disruption.
Despite settlement improvements, users still report unexpected charges and charges continuing after cancellation attempts.
Impact: Settlement didn't fully resolve issues. Extra vigilance required.
Multiple users report 7+ day shipping delays for compounded medications. Coordination issues between teams.
Impact: Treatment gaps possible. Need to request refills early.
No phone support. Chat/app messaging primary channel. Teams don't communicate well.
Impact: Frustrating for users with urgent issues. Escalation often required.
Hims offers compounded semaglutide at $199/month with a simpler medication-focused service. Public company with no major settlement history.
Ro offers similar comprehensive approach with coaching and both compounded and branded options. Brand partnerships remain intact. Also offers 30-day money-back guarantee.
Calibrate offers intensive 1-on-1 coaching and focuses on insurance integration for branded medications. Premium price ($499/month) but may be more cost-effective with good insurance.
Neither Found nor Ro has major class action settlement history. Both offer comprehensive programs. Ro adds money-back guarantee for extra protection.
Complete comprehensive health questionnaire covering medical history, weight loss goals, current medications
System evaluates eligibility for GLP-1 medications based on BMI and health profile
Board-certified physician reviews assessment and medical history
Video or asynchronous consultation depending on state requirements
If approved, prescription sent to partner 503B pharmacy (compounded) or retail pharmacy (branded)
Compounded medications shipped directly to home
Receive medication with SmartDose titration protocol instructions
Access Noom Weight app curriculum, GLP-1 Companion app, and coach support
Ongoing monthly refills with dose adjustments via clinician messaging
Time to First Prescription
Typically 24-48 hours for medical review. Compounded medication shipping takes 5-7 days (some users report delays up to 2+ weeks). Total time to medication: 1-3 weeks.
Consultation Format
Primarily asynchronous telehealth with unlimited messaging to care team. Video consultations available when required by state or requested.
Provider Type
Board-certified physicians licensed in applicable states. Care team includes coaches for behavior change support.
Video Option
Available but not required for all patients. State requirements vary.
Quality Concerns: SIGNIFICANT: Eli Lilly terminated partnership July 2025, stating compounded medication sales are 'breaking the law and putting patient safety at risk.' Legal uncertainty following shortage resolution.
4.4/5 stars
65,000+ reviews
Highly positive overall. Users praise comprehensive approach. Company responds to 99% of negative reviews within 24 hours.
A+ (improved from D after $62M settlement)
1,200+ complaints led to D rating in 2020
Rating improved after class action settlement required business practice changes.
4.5+ stars
Millions of downloads
High ratings for Noom Weight app. Users appreciate psychology-based approach.
Positive assessment
Professional review
Professional reviewers note comprehensive approach differentiates Noom.
"Noom Med is different because it's not just about the medication. The coaching, the psychology lessons, and the GLP-1 Companion app all work together. I've tried other GLP-1 providers but this is the first time I feel like I'm building habits that will last."
— Trustpilot review, January 2026
Billing/Cancellation
"Settlement documents revealed systematic issues with auto-renewal practices including misleading free trial terms, difficult-to-find cancellation options, and charges without separate consent. Former engineer testified cancellation was 'difficult by design' to generate revenue."
— Class action settlement documents, Nichols v. Noom Inc. (S.D.N.Y.)
Eli Lilly Partnership
"Anyone continuing to sell mass compounded tirzepatide or semaglutide products, including by referring to them as 'personalized,' 'tailored' or something similar, is breaking the law and putting patient safety at risk."
— Eli Lilly statement, July 2025
Shipping Delays
"I've been waiting over two weeks for my medication. The clinical team says it shipped, the pharmacy team says they're waiting on approval. Nobody knows what's going on."
— Trustpilot review, December 2025
No dedicated phone support line. Support primarily through app and chat messaging.
support@noom.com
In-app chat messaging to care team and support. Primary support channel.
Noom app and web portal for program access, messaging, and account management
Analysis of Trustpilot reviews (65,000+), BBB complaints, and class action settlement documents
Best Case
Same-day response for clinical questions via app messaging. Company responds to 99% of negative Trustpilot reviews within 24 hours.
Typical
24-48 hours for support requests via app. Clinical team generally responsive.
Worst Case
Billing issues and cancellation requests can take extended time. Historical pattern of 'difficult by design' cancellation per class action.
Medical oversight is appropriate with licensed physicians. However, compounded medications are NOT FDA-approved, and Eli Lilly's safety concerns are notable.
Financial risk is MODERATE due to documented billing issues. Use monthly billing only, credit card for protection, and monitor statements carefully.
Service risk is MODERATE. Clinical support generally good via app but administrative issues persist. Escalation to public channels often required.
Auto-Renewal
YES - Programs auto-renew monthly. $62M class action settlement addressed deceptive auto-renewal practices.
Billing Transparency
IMPROVED BUT CONCERNS REMAIN - Settlement required clearer disclosures and cancel button. Users still report unexpected charges.
Payment Methods
Credit card, debit card. FSA/HSA may be accepted.
Financing
No financing options. Monthly billing available. Avoid annual prepay.
"Anyone continuing to sell mass compounded tirzepatide or semaglutide products, including by referring to them as 'personalized,' 'tailored' or something similar, is breaking the law and putting patient safety at risk."
— Eli Lilly official statement, July 2025
State Restrictions
NY, NJ, RI require insurance coverage for GLP-1 programs.
State-Specific Requirements
Physicians licensed in states where they practice. Telehealth regulations followed.
Pharmacy Board Actions
No pharmacy board actions against Noom documented.
Compounded GLP-1 at $129/month is highly competitive. Comprehensive program adds genuine value vs medication-only. Branded medication programs expensive when adding drug costs to membership.
Board-certified physicians, SmartDose titration, FDA-regulated pharmacies. Deducted for compounded medications lacking FDA approval and legal uncertainty following Lilly termination.
Responsive via app messaging with 99% response rate to negative reviews. However, live support limited, teams don't communicate, billing issues remain difficult to resolve.
Pricing clearly displayed. Settlement required improved disclosures. However, company faced $62M class action for deceptive practices, and users still report unexpected charges.
A+ BBB rating (improved from D) shows accountability. 17 years operational with major funding. However, $62M settlement for 'difficult by design' cancellation and continued compounded sales despite Lilly objections raise concerns.
Noom Med offers a genuinely differentiated approach combining GLP-1 medications with psychology-based coaching, food tracking, and behavior change curriculum. The 17-year-old company has significant institutional backing ($624M+) and documented 39% better weight loss outcomes than medication alone. The A+ BBB rating (improved from D in 2020) shows accountability after the $62M settlement. However, that settlement history and July 2025 Eli Lilly partnership termination create legitimate trust concerns competitors don't have. Choose Noom Med if you want comprehensive behavior change support and plan to eventually transition off medication. Choose alternatives if you want simple, affordable medication access or have concerns about compounded medications' legal status. Rating: 4.0/5
Best Alternative: Ro Body Program — Offers similar comprehensive approach with coaching and both compounded and branded options with intact partnerships. No class action settlement history. 30-day money-back guarantee provides extra protection.
Others: Hims/Hers ($199/month compounded - simpler medication-only), Calibrate ($499/month - premium with insurance focus), Found (comprehensive with insurance integration, no settlement history)
We verified: BBB accreditation status (A+ rating, accredited since October 2021), Class action settlement terms ($62M total), Eli Lilly partnership termination (July 2025), Funding history ($624M+, $3.7B valuation), Pricing for all programs, Trustpilot rating and review count, Company founding date and leadership, State availability restrictions.
We could not verify: Exact current number of active Noom Med subscribers, Specific 503B pharmacy partners, Internal customer service metrics, Company-cited 39% better weight loss outcomes (study not independently reviewed), Current complaint resolution rates.
This review is based on publicly available information including BBB profiles and complaints, Trustpilot reviews, class action settlement documents, court filings, official company materials, news coverage, and regulatory database searches. We have not received payment from Noom for this review.
This review is for informational purposes only and does not constitute medical advice. GLP-1 medications require prescription and should only be used under medical supervision. Consult a healthcare provider before starting any medication. Compounded medications are not FDA-approved.
AllGLP1.com may earn affiliate commissions from providers mentioned in this review. This does not influence our editorial ratings or factual assessments. We maintain editorial independence.
